Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.29 | 2.27 |
NAV | ₹11.82 | ₹169.27 |
Fund Started | 25 Sep 2023 | 13 Oct 2005 |
Fund Size | ₹863.36 Cr | ₹1420.55 Cr |
Exit Load | Exit load of 1%, if redeemed within 12 months. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 2.22% | 9.66% |
3 Year | - | 20.00% |
5 Year | - | 23.01% |
1 Year
3 Year
5 Year
Equity | 97.22% | 96.69% |
Cash | 2.75% | 3.31% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Eternal Ltd. | 8.71% |
Info Edge (India) Ltd. | 8.54% |
PB Fintech Ltd. | 7.15% |
Affle 3I Ltd. | 6.07% |
FSN E-Commerce Ventures Ltd. | 5.44% |
One97 Communications Ltd. | 4.04% |
Indiamart Intermesh Ltd. | 3.98% |
KPIT Technologies Ltd. | 3.94% |
Delhivery Ltd. | 3.76% |
Nazara Technologies Ltd. | 3.42% |
Name | Assets |
|---|---|
Infosys Ltd. | 8.79% |
Reliance Industries Ltd. | 6.82% |
ICICI Bank Ltd. | 6.53% |
HDFC Bank Ltd. | 5.93% |
NTPC Ltd. | 4.63% |
Larsen & Toubro Ltd. | 4.59% |
Bharti Airtel Ltd. | 3.99% |
Sun Pharmaceutical Industries Ltd. | 3.69% |
Tata Consultancy Services Ltd. | 3.01% |
Dr. Reddy's Laboratories Ltd. | 2.87% |
Name | Nitin Jain | Sri Sharma |
Start Date | 01 Oct 2024 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to provide medium to long-term capital appreciation through investment primarily in growth and innovation-oriented equity and equity-related instruments. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 25 Sep 2023 | 13 Oct 2005 |
Description
Launch Date